aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
Timberland Bancorp, Inc. Appoints Kathy D. Leodler to its Board of Directors
May 31, 2017 13:09 pm UTC| Business
HOQUIAM, Wash., May 31, 2017 -- Timberland Bancorp, Inc. (Nasdaq:TSBK) (“Timberland” or the “Company”), the holding company for Timberland Bank (the “Bank”) announced that Kathy D. Leodler, founder and CEO of the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave